Is it too late to buy these high-flying ASX shares?

The Rio Tinto Limited (ASX:RIO) share price is up over 30% in 12 months. Is it too late to buy the mining giant's shares and the shares of…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Although the market has struggled a touch this week, it hasn't stopped a number of popular shares from racing to new highs.

Two that have done this are listed below. Is it too late to buy them?

The MNF Group Ltd (ASX: MNF) share price reached an all-time high of $6.95 on Friday, bringing its 12-month return to over 48%. Although this has left its shares trading at a lofty 38x trailing earnings, I think the online voice communications provider is capable of growing its earnings at a strong enough rate to justify this premium. In fact, at its November annual general meeting management forecast profit growth of 24% for the current financial year.

This level of growth appears to have impressed analysts at Morgan Stanley. According to a note out of the investment bank this week, the broker placed a $7.70 price target on its shares. This implies further upside of over 16% for its shares over the next 12 months. Morgan Stanley is of the opinion that this strong profit growth can continue until at least 2020.

The Rio Tinto Limited (ASX: RIO) share price climbed to a nine-year high of $81.12 today. This rise has been driven largely by improving copper and iron ore prices thanks to bullish global economic growth forecasts. Overnight the 62% fines iron ore price rose to US$79.08 per tonne, its highest level in almost five months.

Despite the mining giant's shares climbing almost 30% over the last 12 months, I still see a lot of value in them. Perhaps not as much value as I see in fellow iron ore producer Fortescue Metals Group Limited (ASX: FMG), but enough to warrant an investment today. Especially considering its shares provide a trailing fully franked 3.7% dividend.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended MNF Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »